Clinical and bacteriological effectiveness of three different short-course antibiotic regimens and single-dose fosfomycin for uncomplicated lower urinary tract infections in women (SCOUT): a pragmatic, multicentre, open-label, randomised clinical trial [0.03%]
Carl Llor,Ramon Monfà,Ana Garcia-Sangenís et al.
Carl Llor et al.
Background: Most guidelines recommend nitrofurantoin, fosfomycin, and sometimes pivmecillinam for uncomplicated urinary tract infections (UTIs), but direct comparisons between these antibiotics are needed. This study eval...
Safayet Jamil,Uzma Asif,Masoud Mohammadnezhad
Safayet Jamil
Jesús Rodríguez-Baño,Pilar Retamar-Gentil
Jesús Rodríguez-Baño
Wei Yen Chan,Ines Pires da Silva,Georgina V Long et al.
Wei Yen Chan et al.
MEK inhibitors are established therapies in BRAF-driven cancers, yet their broader clinical effect is limited by toxicity, resistance, and modest durability as a monotherapy, particularly in RAS-mutant tumours. Dose intensity is often restr...
Joacim Rocklöv,Sarah Dunlop,Thomas C Chiles et al.
Joacim Rocklöv et al.
François Gueyffier,Jim M Wright,Rémy Boussageon et al.
François Gueyffier et al.
Yingxian Sun,Jing Li
Yingxian Sun
James Goadsby,Argyro Syngelaki,Laura A Magee et al.
James Goadsby et al.
David Baud,Joanna Sichitiu,Hélène Legardeur et al.
David Baud et al.
Khushi Gupta,Michael Ghebrial,Chiara Tognaccini et al.
Khushi Gupta et al.